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Deciphering the genetic bases that drive animal diversity is one of the major
challenges of modern biology. Although four decades ago it was proposed
that animal evolution was mainly driven by changes in cis-regulatory DNA
elements controlling gene expression rather than in protein-coding sequences,
only now are powerful bioinformatics and experimental approaches available
to accelerate studies into how the evolution of transcriptional enhancers
contributes to novel forms and functions. In the introduction to this Theme
Issue, we start by defining the general properties of transcriptional enhancers,
such as modularity and the coexistence of tight sequence conservation with
transcription factor-binding site shuffling as different mechanisms that main-
tain the enhancer grammar over evolutionary time. We discuss past and
current methods used to identify cell-type-specific enhancers and provide
examples of how enhancers originate de novo, change and are lost in particular
lineages. We then focus in the central part of this Theme Issue on analysing
examples of how the molecular evolution of enhancers may change form
and function. Throughout this introduction, we present the main findings of
the articles, reviews and perspectives contributed to this Theme Issue that
together illustrate some of the great advances and current frontiers in the field.1. Introduction
In 1859, the publication of Darwin’s The Origin of Species provided a powerful
natural explanation as to how the endless forms most beautiful and most wonderful
have been created on this planet. After 150 years of advances in genetics and
the molecular principles of heredity, the molecular basis of life diversification
can now be understood in its general terms. In the past decade, whole-genome
sequencing has allowed direct observation of the genetic changes that separate
related species in unprecedented breadth, helping us to understand how genetic
variation is generated and opening up the possibility of grasping what genetic
changes make, for example, an elephant different from a mouse.
Confirming pioneering observations [1], whole-genome comparisons show
that protein-coding sequences and repertoire do not vary much between related
organisms, with the exception of proteins related to functions like olfaction,
reproduction and immune defence [2,3]. Coding exons are embedded in a sea
of intronic and intergenic non-coding sequence, the vast majority of which is
devoid of specific functions and constitutes ‘junk’ DNA. However, the non-
coding part of the genome also includes functional regulatory regions, like
enhancers. Transcriptional enhancers determine where, when and how much
a protein-coding gene is expressed in every animal tissue. Because they
encode such critical spatio-temporal and quantitative information, it is expected
that their sequences are under strong purifying selection and mutate at a slower
rate than flanking neutrally evolving regions. Even though enhancers tend to be
evolutionarily conserved, in general they evolve faster than coding regions [4,5],
suggesting that changes in regulatory DNA play an important role in evolution.
Although this does not mean that physiological and morphological changes
cannot be caused by mutations in coding exons [6,7], many characteristics of
enhancers and other cis-regulatory regions indicate that organismal evolution
is mostly driven by changes in gene regulation, as theorized over 40 years
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Figure 1. Schematic of the modular organization of the expression of mouse
Pomc. The neuronal enhancers nPE1 (blue) and nPE2 (red) control expression
in neurons of the hypothalamic arcuate nucleus (Arc). The proximal pituitary
enhancer (PPE; green) drives expression to melanotrophs and corticotrophs of
the pituitary (Pit), whereas the distal pituitary enhancer (DPE; purple) is active
in pituitary corticotrophs. A cryptic hippocampal enhancer, cryHE (orange),
drives reporter gene expression in newborn neurons of the dentate gyrus (DG)
of the hippocampus in transgenic mice. Pomc exons are in black boxes.
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mulated in recent years showing that mutations in regulatory
regions are an important source of evolutionary innovation
[10–13]. Although the relatively rigid genetic code that deter-
mines the amino acid sequence of proteins was deciphered
soon after the discovery of DNA structure, the regulatory code
of the genome still remains an unsolved mystery and, as such,
understanding the complex interplay between regulatory
DNA regions and transcription factors (TF), regulatory RNAs,
signalling pathways and epigenetic marks that determine gene
expression is among themain current challenges ofmodernmol-
ecular genetics. As our knowledge of the regulatory code
progresses, the closer we are to understanding how evolution
operates at the molecular level to bring about morphological
and physiological innovation. This field of research, years ago
mainly supported by those interested in the basic mechanisms
of gene expression regulation, is experiencing a vigorous
growth in medical and human genetics departments interested
in understanding human disease, as developmental defects,
cancer and other conditions are more and more found to be
caused by mutations in enhancers [14–20].
In the introduction to this Theme Issue on Enhancers
Evolution and Animal Diversity, we shall review some general
principles concerning how changes in transcriptional enhancers
happen over time and particularly how they can lead to pheno-
typical innovation. Some principles will be illustrated with our
studies on the regulation of the proopiomelanocortin gene
(Pomc; see figure 1 for a schematic of the structure of mouse
Pomc and its regulatory regions). Pomc encodes a prohormone
expressed in the arcuate nucleus of the hypothalamus and in
the corticotropes and melanotropes of the pituitary which
plays critical roles in the control of energy balance and stress
response in vertebrates [21].2. Enhancers: general considerations
Inanimals, enhancers areoneof themain types of transcriptional
regulatory regions, others being promoters, promoter-tethering
elements, locus control regions, silencers, barrier elements
and insulators. Enhancers are cis-acting segments of DNA,usually mapped down to 200–500 bp, that control expression
of nearby genes. Enhancer activity is thought to depend on the
long-range communication between the enhancer region and
the promoter [22], which is achieved by DNA loopingmediated
by specific proteins like cohesin and the Mediator complex [23],
as well as relocation of the active gene from the periphery to
the interior of the nucleus [24]. Identified enhancers are often
located in the vicinity of the genes they control, but some have
been found up to 1 Mb away [14], even within introns of
other genes (for a recent excellent collection of papers on distal
enhancers, see the Discussion Meeting Issue; [25]).
Since their discovery over 30 years ago [26], enhancers have
been found to harbour several transcription factor-binding
sites (TFBS) in a particular spatial order, defining what can
be called the enhancer grammar. Detailed functional dissection
of different enhancers led to the development of two extreme
models of enhancer organization, the (i) enhanceosome and the
(ii) billboard models [27]. The enhanceosome model is derived
from work on an enhancer that triggers interferon-b (IFN-b)
transcription in response to viral infection. Exhaustive analyses
of this enhancer found that it is composed of a tight ensemble
of binding sites for several TF that need to be present in a pre-
cise order and spacing, as even minor mutations that prevent
binding or alter the distance between bound TF cause the
enhancer not to function at all. TF in the enhanceosome thus
work synergistically as a unit [28]. By contrast, billboard
enhancers are composed of TFBS arranged in a looser and
more flexible way such that the removal of a binding site
diminishes enhancer performance but does not abolish it com-
pletely. The enhancer for stripe 2 of Drosophila even-skipped
(eve), for instance, has an arrangement of TFBS for activators
(Bicoid, Hunchback) and repressors (Kru¨ppel, Giant) that,
when individually mutated, do not abolish its function but
rather change stripe width and intensity in transgenic experi-
ments [29]. For many enhancers analysed in less depth, there
is evidence that removal of large chunks of conserved enhancer
sequence does not abolish enhancer function, also pointing to a
flexible, billboard-like organization, as is the case of the neur-
onal Pomc enhancers nPE2 and nPE1 (figure 1; [30,31]). Few
enhancers have been studied at the same depth as those for
IFN-b and eve stripe 2, but it is possible that for most enhancers
more rigid and more flexible subsegments coexist. The 362-bp
core region of the sparkling (spa) enhancer of Pax2, which drives
expression to cone cells in theDrosophila compound eye, seems
to have an intermediate organization, as spacing and order
of TFBS are important for enhancer function, as in the enhan-
ceosome, but at the same time one of the critical regions for
spa function (region 1) can be relocated without affecting
expression [32,33]. A third model of TFBS organization was
found in enhancers involved in heart development and differ-
entiation [34]. This alternative (iii) TF collective mode of
enhancer activity operates via the cooperative recruitment of
a large number of cardiogenic TFs to activate enhancers with
an apparently lax motif grammar, such that motifs for some
factors may be absent and some necessary TF are rather
recruited via cooperative protein–protein interactions [34].
Apart from the order and number of TFBS, another
important variable in enhancer grammar is TF-binding affin-
ity. Genome-wide analyses indicate that many interactions
between TF and DNA are relatively weak, and these are
regarded as likely to be non-functional [35] as are also
DNA regions bound at low occupancy [36]. However, in
this issue, Ramos & Barolo [37] show that a weak interaction
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enhancer in response to Hedgehog signalling is nevertheless
very important for the correct interpretation of the Hedgehog
gradient in the fly embryo, implying that low-affinity sites
can be functional in some circumstances [37]. Enhancer
grammar also depends on the interactions between bound
TF, and this is reflected by the conservation of distances
between TFBS which is necessary to facilitate these inter-
actions. In this issue, Guturu et al. [38] take into account
DNA sequence and protein structural data to predict regions
bound by TF on phylogenetically conserved elements in the
genome, generating an original, free database of potential
TF complexes for future studies on enhancer organization
and function [38].R
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During embryonic development and in each tissue of the
adult body, different cell types express distinct groups of
TF and are exposed to various cell-signalling pathways,
giving rise to a unique combinatorial regulatory code that
is interpreted by DNA regulatory regions, like enhancers, to
ultimately determine whether a particular gene will be on
or off in a given cell type. Genes with complex expression
patterns have been experimentally shown to have several
enhancers, each of which drives expression in particular cell
types or time points. This modular organization allows
each enhancer to control gene expression in a strict spatial
and temporal domain independently of each other and of
the basal promoter. For example, the mouse Sonic hedgehog
homolog gene (Shh), which encodes a secreted morphogen,
has at least six enhancers controlling its expression in several
parts of the neural tube [39], as well as one distal enhancer
controlling expression in the limb bud [14,40]. Neuronal
enhancers nPE1 and nPE2 drive Pomc expression to hypo-
thalamic neurons independently of the pituitary enhancer
or promoter, and vice versa (figure 1; [41,42]). The functional
modularity of enhancers is best illustrated by targeted muta-
genesis experiments. For example, the removal of a distal,
limb-specific enhancer of Shh causes limb truncations in
mutant micewithout causing aberrant phenotypes in the noto-
chord or neural tube, which also express Shh [40]. It is
important to note, however, that enhancers may not be absol-
utely modular. For instance, some enhancers can synergize
with each other, as the case of Shh forebrain enhancers in
zebrafish [43]. Recently, a thorough characterization of the
200 kb-regulatory landscape of the mouse Fgf8 gene, which
encodes a secreted signalling protein, has shown that the rela-
tive position of enhancers in relation to the controlled gene is
important to fine-tune the expression pattern of the gene [44].
In any case, enhancer modularity has important evolutionary
consequences, as mutations in a particular enhancer will
change the expression of a gene in a particular region with
no or minor effects in other regions, i.e. with little or no pleio-
tropic effects associated (see §6). Another important, emerging
feature of gene regulation is that manymetazoan genes possess
more than one enhancer driving partially or completely
overlapping expression patterns [45,46]. In flies, many devel-
opmental genes carry two enhancers with overlapping
functions; the enhancer closer to the genewas called ‘primary’,
whereas the one farther way was named ‘shadow’ enhancer
[47]. The existence of functionally overlapping enhancers isnot restricted to developmental genes. For instance, Pomc has
two distinct enhancers that drive expression to the same popu-
lation of hypothalamic neurons [31,42]. Even the expression of
Pomc in the pituitary, long thought to be driven only by the
proximal enhancer and promoter, was recently found to
depend also on an enhancer with the same regulatory activity
as a proximal enhancer (figure 1; [41]). Functionally overlap-
ping enhancers may confer robustness, buffering gene
expression against environmental and genetic disturbances
[48,49]. Enhancers with partial redundant activity are also
hypothesized to be a potential source of evolutionary novelty,
as such systems might be more tolerant to mutations that lead
to new expression patterns [47].4. Identification of enhancers and functional
studies
Identifying enhancers in genomes is crucial for the understand-
ing of the complexity and mechanisms of gene regulation [50].
Traditionally, regulatory regions have been identified and
mapped by cloning candidate sequences upstream of a mini-
mal promoter fused to a reporter gene and testing their
transcriptional activity in cell lines or in transgenic organisms.
Although more laborious and expensive to make, transgenic
animals have the great advantage of providing complete
spatio-temporal expression information simultaneously in all
tissues and cell types of an overall healthy animal. More and
more laboratories map enhancers using 100–200 kb bacterial
artificial chromosomes, which allow for the testing of regula-
tory regions in a context that better resembles the endogenous
one, compared with small constructs [51]. Detailed studies
using these methods have determined that genes involved in
embryonic development are controlled by several enhancers,
like the example of the mouse Shh gene mentioned in §3 or
the chicken Sox2 gene encoding a TF controlled by at least 11
enhancers arranged in a 50 kb region surrounding the gene
[52]. This is not surprising because the expression of develop-
mental genes need to be precisely controlled both spatially
and temporally in many different tissues. However, even
genes not involved in development may have several enhan-
cers, like Pomc, which is controlled by two distal enhancers in
the hypothalamus and byone distal and one proximal enhancer
in the pituitary (figure 1; [41,42]). These and many other
examples indicate that the number of enhancers in every
animal genome is substantially larger than the number of
protein-coding genes.
Beginning in the early 2000s, the sequencing of the genomes
of several species allowed for the identification of enhancers
and other non-coding DNA elements by phylogenetic foot-
printing [53]. This technique is based on the idea that DNA
sequences that play a functional role evolve slower than non-
functional sequences, which are freer to accumulate neutral
mutations [54]. Thus, comparing the genomes of an appropriate
set of organisms allows one to identify DNA elements under
evolutionary constraint and differentiate them from neutrally
evolving sequences. Conserved non-coding sequences (CNE),
when experimentally tested, often turn out to display enhancer
activity [55–58]. Deeply conserved CNE (i.e. conserved in all
vertebrates) are more often found around genes involved in
early development, presumably because mutations in enhan-
cers that control the precise regulatory patterns of such genes
often cause deleterious developmental phenotypes [59,60].
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allowed for the mapping of evolutionary constraint in great
detail, showing that 4.2% of mammalian genome sequence is
phylogenetically conserved [61]. Within the conserved fraction,
around 68% is located in intronic or intragenic regions (i.e. out-
side exons and promoters), and at least 30% of the conserved
fraction overlaps chromatin marks typical of enhancers [61].
Some CNE display extreme levels of conservation (ultracon-
served sequences or UCE), reaching 100% sequence identity
in mammals [62], and some orthologous CNE have even been
found to be present in invertebrates and vertebrates [5,63].
The challenges posed by the study of CNE, in particular the
study of their evolutionary dynamics and function, are the
topic of a review by Harmston et al. in this issue [64], while
another review by Maeso et al. [65] deals with the challenge
of identifying and analysing transphyletic CNE.
In recent years, chromatin immunoprecipitation coupled
to microarray hybridization (ChIP-CHIP) or DNA sequencing
(ChIP-seq) has allowed for the genome-wide mapping of TFBS
and the mapping of chromatin (‘epigenetic’) marks in the form
of specific histone posttranslational modifications [66,67].
Tracing the distribution of such features—as well as regions
of open chromatin detected by whole-genome mapping
of DNase I hypersensitive sites—can be used to identify
potential enhancers at a genome-wide scale [68,69]. Thus,
enhancer regions are bound by clusters of TF [70–72] and
are often associated with transcriptional cofactors p300/
CBP (a histone acetylase) and components of the Mediator
complex [23,73]. Active enhancers are also associated with
specific histone marks like histone H3 lysine 4 monomethy-
lation (H3K4me1) and histone H3 lysine 27 acetylation
(H3K27ac), as well as depletion in H3 lysine 4 trimethylation
(H3K4me3), which mark promoters (reviewed in [60,61]). In
the human genome, the ENCODE Project identified around
400 000 elements bearing enhancer-like chromatin signatures
in the cell lines that were analysed [74], while around 230 000
potential enhancers were found in the mouse genome using
similar techniques [75]. The utility of sequence conservation
as well as whole-genome ChIP techniques to identify and
study the evolution of enhancers is reviewed in this issue by
Sakabe & Nobrega [76].
It is important to note, however, that the evidence pro-
vided by the genome-wide mapping of genomic features is
just an indication of potential enhancer activity and should
not be taken as equivalent to regulatory function [77,78].
Indeed, it is expected that the large genome of complex
organisms is alive with biochemical activity, including TF
binding, with no significant physiological consequences for
the organism [77,79–81]. As an indication of this, it has
been recently shown that DNA sequences generated at
random can display a significant degree of transcriptional
regulatory activity in mammalian cells [82], indicating that
even expression assays in cells or transgenic models may be
deceptive and that more detailed experimental evidence is
necessary before assigning enhancer function to a sequence.
Around 1 kb upstream of mouse Pomc, we have serendipi-
tously found a non-conserved regulatory region which
drives reporter expression to the subgranular layer of the den-
tate gyrus of the hippocampus of transgenic mice (figure 1;
[83]) and is being used as a reliable marker of newborn neur-
ons in this brain region [84]. Because Pomc is not expressed in
the hippocampus, it may well be that this enhancer activity
is used by another gene in the vicinity or just represents aconsistent artefact, especially considering that this DNA
sequence is not conserved in other mammals.5. Molecular evolution of enhancers
Although purifying selection keeps transcriptional enhancers
evolving at a slow pace in relation to non-functional DNA,
enhancers do change by the accumulation of point mutations
and small insertions and deletions. In addition, new enhan-
cers can appear by chance when random mutations create
clusters of TFBS or lost when large deletions eliminate enhan-
cer sequences. Such processes can be driven by natural
selection as well as purely neutral mechanisms [85]. Ulti-
mately, turnover of TFBS in enhancers as well as the birth
and elimination of enhancers cause the regulatory element
repertoire to change over evolutionary time. An indication
of this is that while a third of the coding bases are conserved
between mammals and amphioxus (a chordate that belongs
to a sister group of vertebrates), less than 1% of CNE bases
(a proxy for enhancers) are conserved between these groups
[5]. Thus, TFBS reshuffling and enhancer turnover seem to
be two pervasive mechanisms setting up hurdles on the
way towards the discovery of a universal transcriptional
regulatory code, in contrast to the straightforward transla-
tional code unravelled in the 1960s that allows predicting
protein identity directly from DNA sequence. The variety of
rules already found in the regulatory code are perplexing,
as illustrated by the titles of two recent papers on the subject:
the review ‘Conserved expression without conserved regula-
tory sequence: the more things change, the more they stay
the same’ [86] and the research paper ‘Minor change, major
difference: divergent functions of highly conserved cis-regulat-
ory elements subsequent to whole genome duplication events’
[87]. If the former addresses the concept that the regulatory
logic of a functional enhancer can be retained in the absence
of detectable sequence conservation, the latter indicates that
even small mutations present in highly conserved enhancers
may lead to profound functional differences. As understanding
the transcriptional code and its impact on the evolution of form
and function will be more challenging than anticipated, efforts
must be redoubled to study how gene expression is modified
by enhancer birth, change or loss.
(a) The birth of an enhancer
Genetic mechanisms leading to the birth of novel enhancers
include: (i) insertion of transposable elements (TEs), (ii) de
novomutations and (iii) chromosomal rearrangements that pro-
mote enhancer adoption. The high contribution of TE-derived
sequences to genome composition provides a substantial
amount of raw material with the potential to evolve into novel
functional cis-regulatory elements. Probably the first convincing
case was a sequence derived from a HERV-E retroposon that
became co-opted as a parotid-specific enhancer of the human
salivary a-amylase 1C gene (AMY1C; [88]). Interestingly, inser-
tion of this TE in the 50 proximal flanking region of a paralogue
copy of the ancestral pancreatic AMY2B occurred in the lineage
leading to primates [89] which acquired, therefore, the possi-
bility to taste rewarding sweet sugars produced by the
enzymatic processing of starch. More recently, the 29Mammals
Project has found more than 280 000 conserved, TE-derived
non-coding elements [61,90]. Although these elements carry
potential cis-regulatory function, exaptation (co-option) of
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rigorously demonstrated in transgenic animals in only a hand-
ful of cases [77]. For example, we have found that the
neuronal Pomc enhancers nPE1 and nPE2 originated from two
independent exaptation events, an example of convergent
evolution of transcriptional enhancers [31,91], whereas
nPE2 derived from a CORE-SINE retroposon [30] in the
lineage leading to mammals, nPE1 is a more recent placental
acquisition derived from a mammalian apparent LTR (MaLR)
retroposon [31].
Eichenlaub & Ettwiller [92] have recently discovered that
enhancers can originate de novo after acquiring minor changes
in previously existing non-regulatory sequences [92]. By taking
advantage of the massive gene loss following the last whole-
genome duplication in teleosts, these authors identified four
ancient exons that lost their coding capacity in teleosts and
were exapted as transcriptional enhancers of nearby genes, as
demonstrated in transgenic medaka embryos [92]. Gene con-
version may promote the adoption of an enhancer previously
used by another gene, as shown by the group of Mike Levine
in the beetle Tribolium castaneum in which a cardiac enhancer
located in the 30 flanking region of the ladybird gene was relo-
cated to the 50 end of the neighbouring gene C15. This
inversion, therefore, promotes the cardiac expression of C15
in Tribolium [93].(b) Enhancers change, function not always
That enhancers can changewithout modifying their regulatory
activity is best illustrated by the even-skipped stripe 2 enhancer
(S2E) in species of the Drosophila genus, in which the shuf-
fling of TFBS within the S2E of different species leads to the
same expression pattern in transgenic Drosophila melanogaster
embryos [94,95]. Even the orthologous eve enhancers of
sepsid flies, which are distant relatives of Drosophila and
whose enhancer sequences are very different, can drive equiv-
alent expression in transgenic D. melanogaster embryos [96],
showing that enhancers with different arrangements of TFBS
can correctly interpret a TF code and give rise to the same
expression output. Importantly, in complementation experi-
ments, the divergent Drosophila pseudoobscura S2E perfectly
rescued the embryonic lethal phenotype of mutant
D. melanogaster carrying homozygous deletions of S2E, prov-
ing that two enhancers with highly different sequences can
be functionally interchangeable, at least when tested in the lab-
oratory [95]. Thus, stabilizing selection is reminiscent of the
politically cynical ideas of the Sicilian Prince of Salinas who
in the novel ‘The Leopard’ by Guisseppe Lampedusa
published in 1957 stated that ‘everything needs to change,
so everything can stay the same’. In vertebrates, this scenario
is illustrated by experiments in which mammalian enhancers
can drive appropriate expression in zebrafish embryos even
in the absence of obvious sequence identity. For example,
Fisher et al. [97] analysed human enhancers of the RET locus
in zebrafish and found that 11 out of 13 drove equivalent
reporter gene expression in zebrafish, even though no ortholo-
gous zebrafish enhancers could be found by sequence
comparisons. In this issue, Domene´ et al. [98] show that the
mammalian Pomc enhancers nPE1 and nPE2 drive expression
to POMC neurons of zebrafish embryos, even though their
exapted origin from TEs in the early stages of the mammalian
radiation [30,31] rules out the possibility that they are ortholo-
gous to the teleost enhancers.Contrarily to the cases described above, there are examples
in which conservation and high sequence identity may be
functionally deceiving as has been reported for the zebrafish
Shh enhancers ar-D [50 proximal], ar-A (intron 1) and ar-C
(intron 2) that are highly conserved at the sequence and
location level with their corresponding mouse orthologues,
but which direct expression to different expression territories
in each animal, demonstrating that the function of the structu-
rally conserved enhancers has diverged during vertebrate
evolution [43]. Similarly, but at the paralogue level, the ar-C
enhancers of the fugu shha and shhb genes carry minor
sequence changes that, however,modify the expression pattern
of reporter genes in transgenic zebrafish embryos [99].
Hox genes also provide a great setting where to look for
enhancer evolution between duplicate paralogues. Half a
billion years ago, the ancestral Hox gene cluster became quad-
ruplicated in the vertebrate lineage, generating novel Hox
genes paralogous after two consecutive events of tetraploidi-
zation. Hoxa1 and Hoxb1 are indispensable for proper
hindbrain segmentation as has been demonstrated in individ-
ual knockout mice. Analysis of these mutant mice showed
that no active paralogue was able to compensate for the lack
of the loss-of-function copy, suggesting subfunctionalization.
Indeed, it is known that Hoxa1 lost its ability to autoregulate
its expression levels, whereas Hoxb1 lost the responsiveness
to retinoic acid. In a reverse evolution experiment, Tvrdik &
Capecchi [100] reconstructed the ancestralHox1 gene by insert-
ing the autoregulation enhancer of Hoxb1 into the 50 flanking
region of Hoxa1 in the context of a Hoxb1 null-allele mutant.
The resulting enhancer knockin/gene knockout mice sur-
prisingly showed normal development, demonstrating that
subfunctionalized gene paralogues can be reset to the primitive
state and replaced with a single copy provided that both
paralogue proteins retain equivalent activities.
Of course, enhancer evolution can also lead to divergent
expression patterns, possibly driving phenotypical innovation.
The introduction of novel TBFS into pre-exisiting functional
enhancers may allow a gene to acquire expression in an
additional spatio-temporal domain without affecting its ances-
tral expression pattern. Rebeiz et al. [101] reported that the
neprilysin-1 gene (Nep1) of Drosophila santomea has gained a
novel expression pattern in optic lobe neuroblasts after
accumulating four mutations near a pre-existing intronic
enhancer responsible for driving Nep1 expression to ancestral
areas such as the ventral ganglion and the retinal field. In
this issue, Glassford & Rebeiz [102] expand on their previous
work by systematically testing the mutational paths that led
to the accumulation of these four mutations. Interestingly,
their results indicate that some of the paths were prohibited
due to fitness costs associated with epistasis [102].(c) Enhancers come and go
Enhancers are not onlymodified or created de novo but may also
be lost during the course of evolution aswill be further discussed
in §6a. Bejerano and co-workers [103] found that hundreds of
conserved non-coding genomic regions are independently lost
in distinct mammalian genomes, raising the possibility that
some of them could be involved in lineage or species-specific
morphological variation. The existence of functionally overlap-
ping or near redundant enhancers provides a genetic substrate
for this type of mechanism to occur; the surprising lack
of detectable differential phenotypes in four different strains of
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that animals may lose sequences selected for millions of years
without notable deleterious effects, at least in the comfortable
environment of a laboratory animal facility.
Another interesting evolutionary mechanism that induces
loss of function of tissue-specific enhancers is the appearance
of a novel transcriptional repressor that silences previously
active enhancers, as has been reported in a recent study of
the molecular evolution of the vertebrate paralogues pax2
and pax8 [105]. In Xenopus laevis tadpoles, pax2 is expressed
in several cell-types, whereas pax8 is expressed only in a
subset of pax2-expressing tissues. Despite this difference, pax2
and pax8 share several paralogous, conserved non-coding
elements that, individually, recapitulate a pax2-like reporter
expression pattern when ligated upstream of a minimal
b-actin promoter and tested in transgenic tadpoles. Surpris-
ingly, when the b-actin promoter was replaced by the
Xenopus pax8 proximal promoter, the pax2 and pax8 enhancers
drove a more restricted pax8-like expression pattern, demon-
strating that the ancestral enhancers of pax2 and pax8 are
equally able to direct pax2-like, multi-tissue expression,
except when placed upstream of a silencer present in the
pax8 proximal promoter that suppresses expression outside
the pax8-expressing tissues [105].6. Enhancer evolution and animal diversity
What about real data indicating that mutations in enhancer
sequences underlie evolution of important traits? The
number of detailed studies of phenotypic diversification
driven by enhancers is still very small, and the difficulty in set-
ting up such experiments lies in the necessity of having (i) an
easy-to-spot phenotype that displays intra- or interspecific
variation; (ii) knowledge of gene(s) that control(s) such pheno-
type; (iii) detailed data on the DNA sequences (promoter
and enhancers) that regulate the genes in the relevant organ/
structure; (iv) sequence information from related species or
populations inwhich the phenotype shows a relevant variation
and (v) an amenable experimental system with which to
perform functional studies with the different versions of the
enhancer, usually by transgenesis.
Owing to this complexity, most studies on the importance
of cis-regulatory variation in species evolution and adap-
tation do not go very deep. Phenotypic variation at many
interesting traits is known to be controlled by cis-regulatory
divergence, but usually the DNA sequences behind the vari-
ability are unknown. For instance, it is well established that
colour pattern in wings of Heliconius butterflies is linked to
divergent regulation of the optix gene, but the cis-regulatory
sequences are still to be found [106,107]. In other examples,
nucleotide polymorphisms linked to a trait are known but
their regulatory role has not been analysed in great detail.
One example of the latter case is lactase expression in
human populations. Several pastoralist human populations
around the world have independently evolved the capacity
to express lactase during adulthood, which allows digestion
of milk and dairy products. Many polymorphisms linked to
the persistence of lactase expression in adults are known, all
of them located on an intron of an adjacent gene [108]. The
intronic region is conserved only in primates and displays
enhancer activity in cell culture assays, but a detailed charac-
terization of lactase regulatory elements and its variants in amore physiological model, like transgenic mice, is still lacking
[108,109]. In other cases, suggestive differences in enhancer
sequence and activity between species are known, but the
derived expression pattern cannot be linked to a trait.
A detailed understanding of the relation between enhancer
evolution and trait variation is only possible by series of
studies of a particular locus in several species or populations.
Table 1 shows a list of studies that provide compelling evidence
as to how enhancer sequence evolution has contributed to
specific traits in animals. The examples illustrate various mech-
anisms that lead to divergence of enhancer function: deletions,
modification in the TFBS repertoire and acquisition of new
enhancer regions.
(a) Enhancer deletion and phenotypic variation
A dramatic mechanism of enhancer evolution is simply the de-
letion of an enhancer, which leads to the loss of gene expression
in a particular region of the body. A good example concerns a
pelvic enhancerof thePitx1gene in the three-spined stickleback,
a teleost fish that lives in the sea as well as in North American
and Northern European freshwater lakes. Marine sticklebacks
possess bony spines in the pelvic region, presumably as protec-
tion from predators; freshwater populations, on the other hand,
usually lack large pelvic armour. Development of such spines
depends on the activity of a TF, Pitx1, which is expressed in
the pelvic region under the control of a specific enhancer
[111,112]. Several freshwater stickleback populations lack
spines due to deletions of the pelvic enhancer; interesting-
ly, deletions have happened independently several times in
isolated populations of freshwater sticklebacks [111,112].
Other likely cases of enhancer deletions during evolution
have been uncovered by McLean et al. [114], who identified
509 instances of non-coding DNA regions which are conserved
in mammals but have been deleted since the split between
humans and chimpanzees. One of the sequences absent in
humans is an enhancer of the androgen receptor (AR) gene that
drives expression to vibrissae (sensory hairs in the face) and
the genital tubercle during development [114]. Testosterone
is necessary for sensory vibrissae growth and for the develop-
ment of penile spines, structures that are present in rodents and
non-human primates but absent in our species. Thus, a reason-
able hypothesis is that the loss of an AR enhancer in our close
ancestors led to morphological change in our lineage [114].
Thus, the work on teleost Pitx1 and mammalian AR shows
that deletion of enhancers that control the expression of a TF
in a particular region can cause evolution to happen by large
steps, eliminating whole morphological structures provided
that the lack of such structures (like pelvic and penile spines)
are not selected against. Another enhancer deletionwith poten-
tial functional significance uncovered by McLean et al. [114]
affects the expression of the tumour-suppressor gene
GADD45G, whichmight be related to human-specific neuronal
proliferation in the forebrain.
(b) Evolution by mutations in TFBS
Another, more subtle way of enhancer evolution is via point
mutations and small indels that either create or eliminate
TFBS within an enhancer, thereby changing its activity. Sever-
al enhancers that control pigmentation in flies of the genus
Drosophila are known to have evolved in this way. The yellow
gene, which encodes an enzyme involved in pigment syn-
thesis, is expressed in the Drosophila wing under the control
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is lowand steady throughout thewing, leading to uniform pig-
mentation. In Drosophila biarmipes, in contrast, yellow is highly
expressed in a corner of the wing, creating a dark spot [117].
Dark spots on the wings may have a function during
wooing, when males execute an elaborate dance to females.
Analyses of enhancer sequence differences and transgenic
assays indicate that the spot enhancer in D. biarmipes has sites
for a transcriptional activator (recently identified as Distalless)
[118] as well as for the repressor Engrailed, the latter respon-
sible for setting the posterior boundary of the yellow spot
[117]. In a subsequent work, Prud’homme et al. [119] checked
for the presence of wing spots throughout Drosophila phyl-
ogeny and found that independent gains and losses of the
wing spot have happened a couple of times during the evo-
lution of the genus. Loss of the wing spot in Drosophila
gunungcola and Drosophila mimetica happened by mutations
in the same spot enhancer, in a case of convergent phenotypic
evolution driven by change in the same regulatory element
[119]. Notably, gain of wing spot in Drosophila tristis, which
primitively lacked a spot, happened not by mutations in the
spot enhancer, as in D. biarmipes, but in another enhancer
located in a yellow intron that directs expression to wing veins
[119]. Thus, a remarkably similar phenotype—the dark spot
on the upper right corner of the wing—was independently
generated by the co-option of two different yellow enhancers
during fly evolution [119].
Yellow is also involved in the male-specific pigmentation of
the abdomen, where its expression is controlled by the body
enhancer [120]. In D. melanogaster and D. pseudoobscura, body
enhancer activity depends on the binding of TF Abdominal-B
(Abd-B), but the TFBS responsible for binding have been lost
in the body enhancer ofDrosophila kikkawai, which lacks abdomi-
nal pigmentation [120]. In another species lacking abdominal
pigmentation, D. santomea, it is the expression of tan that is
altered [124]. tan is an enzyme with functions in pigmentation
and vision. Its expression depends on an enhancer that is con-
served in the Drosophila genus, but in D. santomea at least three
different kinds ofmutations, includingpointmutations anddel-
etions, render the enhancer non-functional in the abdomen,
which stays unpigmented [124]. Also variation in an enhancer
of ebony, which encodes an enzyme related to pigmentation,
was found to be related to abdominal pigmentation in African
D. melanogaster populations [125].
Another variable phenotype in flieswhich has been studied
in great depth is trichome development in Drosophila larvae.
The precise pattern of trichomedistribution depends on several
enhancers that control the expression of the TF shavenbaby (svb),
as illustrated by Stern & Frankel [126] in this issue, who
summarize 13 years of continuous work on the evolution of
shavenbaby expression in several Drosophila species. Quartern-
ary trichome loss in Drosophila sechellia larvae is due to
several (at least five) point mutations in one particular enhan-
cer, E6, which reduce svb expression in the area of the larvae
that gives rise to quartenary trichomes [121]. Interestingly,
each mutation in the E6 has a small effect per se, so that signifi-
cant reduction is svb expression is only achieved when all sites
are mutated. Thus, loss of enhancer activity can be brought
about not only by enhancer deletion but also by the accumu-
lation of point mutations with small effect, possibly to avoid
pleiotropic effects caused by complete enhancer loss [121].
In tetrapods, limb anatomy and length is partially con-
trolled by the TF Prx1. Forelimbs in bats are much longer
rstb.royalsocietypublishing.org
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replacing a mouse Prx1 limb enhancer with the orthologous
enhancer from a bat caused the limb of mutant mice to be
a little longer, indicating that mutations in the enhancer
alter its activity and contribute to the evolution of forelimb
anatomy [113]. Another recent example of enhancer
mutations driving innovation is the work by Guerreiro et al.
[116] on the axial anatomy of snakes. Vertebrae in tetrapods
can usually be subdivided into several types (cervical, thor-
acic, lumbar, sacral and caudal). Snakes, on the other hand,
are characterized by a homogeneous vertebral anatomy,
with a great number of thoracic-like, ribbed vertebrae. In ver-
tebrates, rib formation at posterior levels of the column is
repressed by TF Hoxa10, but in snakes this repression does
not take place [127]. Studying an enhancer of Myf5, a gene
necessary for proper axial development, Guerreiro et al.
[116] identified sites that can bind to TF Pax3 and Hoxb6,
which act as activators, and Hoxa10, which is a repressor
[128]. In snakes, there is a single nucleotide substitution in
the enhancer that prevents Hoxa10 binding without interfer-
ing with activator binding, which likely explains why ribbed
vertebrae are formed in snakes despite of Hoxa10 expression
not being altered in this group [116,129].
(c) Acquisition of new enhancers and
expression territories
During evolution, it is certain that new regulatory activities
originate not only by tinkering with pre-existing enhancers
but also by the appearance of new enhancers. Patterns of
CNE distribution suggest that new enhancers played a role in
several stages of vertebrate evolution [130], while a burst of
co-option of transposons as new cis-regulatory elements is
associatedwith the reproductive innovations of placental mam-
mals [131,132]. Recently, mapping of enhancer chromatin
marks (H3K27ac) at equivalent stages of limb development in
mouse, macaque and human uncovered many putative enhan-
cerswhich seem to be active only in the developing human limb
and which might contribute to the specific limb phenotype of
our species [133].
An important event in the history of vertebrates was the
morphological transition from a fin to a limb in the ancestor
of tetrapods. Expression of genes of the Hoxd group are more
intense in the developing limbs of tetrapods compared with
developing fins of fish, and it has been hypothesized that
this feature might be related to the differences in the mor-
phology of these structures. Recently, Freitas et al. [115]
found that overexpression of Hoxd13 in the zebrafish develop-
ing fin causes increased proliferation of the chondroskeleton,
which acquires anatomical and molecular characteristics
similar to a tetrapod fin. In addition, they show that a tetra-
pod-specific Hoxd enhancer, CsC, drives robust expression
to the fins of transgenic zebrafish, showing that the trans-
acting factors ready to overexpress Hoxd were in place
before the appearance of the tetrapod limb [115,134].
Many of the studies described above that pinpoint enhan-
cer mutations leading to morphological innovation began by
mapping a large-effect genetic locus responsible for variation
in closely related species or populations [135–138]. Mapping
may also detect genomic regions with signs of a selective
sweep, an indication that natural selection is fixing a variant
in the population. In this issue, Glaser-Schmitt et al. [139]
describe a selective sweep around an enhancer of the CG9509gene (encoding an enzyme of unknown function) that is
responsible for a consistently higher expression of this gene
in European versus sub-Saharan African populations of
D. melanogaster. Increased expression of the enzyme outside
sub-Saharan Africa likely indicates that this phenotype has fit-
ness value, perhaps because the enzymemay have detoxifying
functions [139].7. Enhancer evolution in humans
In their seminal paper, King &Wilson [1] observed that chim-
panzee and human proteins were exceptionally similar in
sequence and deduced that the differences between these
species should mainly be due to mutations in regulatory
DNA. Testing this idea is not an easy task due to the lack
of appropriate model organisms to manipulate [140], but
the work of McLean et al. [114] discussed above indicates
that, at least for some traits, highly suggestive experimental
evidence can be obtained for the identification of human-
specific, non-coding mutations that helped mould our
species. In this regard, sequences displaying signs of acceler-
ated evolution in humans often have enhancer activity and
might be responsible for human-specific phenotypic adap-
tations [141]. One example is element HACNS1, a limb
enhancer showing evidence of accelerated evolution in the
human lineage [142]. In transgenic mice, human HACNS1
shows an increased transcriptional activity compared with
the chimpanzee and macaque orthologous enhancers [142],
probably due to mutations that prevent the binding of repres-
sors of the gene [135]. Although it has been hypothesized that
this might be linked to the evolution of limb morphology, the
gene controlled by HACNS1 is unknown and no experimental
evidence for a function in limb development is available
[142]. In this issue, Capra et al. [143] combine data on non-
coding human accelerated regions with genome-wide sur-
veys of chromatin marks and binding of transcription
factors and cofactors to identify potential enhancers. Experi-
mental testing of a set of human and chimpanzee enhancer
orthologues indicates that most can work as enhancers in
transgenic mice and, consistent with the evidence for positive
selection in humans, many of them have different regulatory
activity between the species [143]. These human accelerated
regulatory sequences, together with other putative human-
specific enhancers found in genome-wide surveys [142,144],
are a rich dataset for the discovery of the peculiar gene regu-
lation features that make us human. Taking advantage of
some of these databases, the group of Lucı´a Franchini identi-
fied the genes carrying the highest number of human-specific
accelerated sequences [141]. The developmental brain gene
NPAS3 is at the top of this ranking with up to 14 elements
that are highly conserved in mammals, including primates,
but carry human-specific nucleotide substitutions. In this
issue, Kamm et al. [145] study the accelerated element
2xHAR142 present in intron 5 of human NPAS3 and show
that the mouse and chimp 2xHAR142 orthologues behave
as transcriptional enhancers in transgenic mice driving
lacZ expression to similar regions of the central nervous
system where mouse Npas3 is normally expressed. Interest-
ingly, the human 2xHAR142 orthologue extends the area of
lacZ expression to the developing anterior telencephalon, pro-
viding an example of human-specific heterotopy promoted
by an accelerated transcriptional enhancer that could have
r9
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Deciphering the genetic mechanisms that operated during the
past 650 Myr of animal evolution to create the seemingly infin-
ite variety of animals that populate our planet has been one
of the holy grails in biology. However, it is only recently
that scientists have developed a number of experimental
tools that allow study of these problems that were much
more difficult to tackle in the pre-genomic era (before ca
2005). The idea of putting together this Theme Issue comes
at a critical time in which the massive availability of
genome sequences from several species, coupled to single-
and multiple-gene functional studies in transgenic organisms
and sophisticated maps of chromatin features have produced
an unprecedented impact in the identification of potential
cell-type-specific enhancers with functional roles in different
lineages or species. We are just beginning to understand the
different possible mechanisms by which enhancers evolve
and contribute to novel forms and functions. The limited
number of examples documented in the literature, most of
which are listed above, are certainly but the tip of the iceberg,
as hundreds of thousands of candidate enhancer sequences
have been identified by sequence conservation and enhan-
cer-associated chromatin marks in many different animal
genomes. However, to make sense of whole-genome surveys
and bioinformatic predictions, it will be important to further
develop the methods to evaluate regulatory function in vivo,
because the data derived from genome-wide studies are
descriptive in nature. In this regard, novel techniques have
been recently developed to test the regulatory activity ofDNA elements at a large scale (see for instance ref. [82]), some-
thing that should help functional studies to keep pace with
genome-wide surveys. In addition to reporter gene assays, it
will also be desirable to accelerate the study of enhancers by
loss-of-function assays, which is perhaps the best way of evalu-
ating the function of a DNA sequence. In recent years,
promising novel genome-editing techniques based on the use
of prokaryotic CRISP/Cas9 nuclease [146,147] and the tran-
scription activator-like effector nucleases [148–150] have
emerged and may be rapidly adapted to make loss-of-function
studies of enhancers in several vertebrate and invertebrate
species, including those organisms inwhich regulatory regions
knockoutswere, until now, not amenable, as have been recently
achieved in zebrafish [148,151,152] and medaka [150]. The use
of these novel techniques will certainly accelerate discoveries
in the field of enhancer evolution and animal diversity.
The articles, reviews and perspectives that follow this intro-
duction shed more light in the still murky and mysterious
world of gene expression evolution in the animal kingdom.
Each of these papers, in one way or another, consolidates the
idea that there will probably be no fixed law, like gravity, to
explain at the molecular level how endless forms most beautiful
and most wonderful have been, and are being evolved. It rather
seems that a wide variety of peculiar molecular mechanisms
perform, together, the complex task of putting the genome in
action, in each cell type of each animal species, at every
moment in life and under every possible physiological and
environmental circumstance.Funding statement. This work was supported by an NIH grant no.
DK068400 (M.R.), Agencia Nacional de Promocio´n Cientı´fica y Tec-
nolo´gica, Argentina (M.R. and F.J.S.) and Universidad de Buenos
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